India, April 2 -- Men with early-stage metastatic prostate cancer may soon be able to postpone the debilitating side effects ...
The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Stephanie Lira discussing scaling operations in theranostics clinical research. There has been tremendous ...
EANM has joined as co-organiser of the European Multidisciplinary Congress on Urological Cancers (EMUC26), bringing nuclear medicine expertise to Europe’s leading congress on urological ...
The 2026 PSMA & Beyond conference featured a session on challenges of radioligand therapy and a presentation by Dr. Michael Hofman discussing the expansion of the theranostic dream. Only 8 years ago, ...
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Often confused with radiology and radiotherapy, nuclear medicine uses radioactive substances to precisely diagnose and treat ...
A randomized study in 58 men with limited metastatic prostate cancer found that PSMA therapy postponed the need for hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results